Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FW.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FW.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
FY.1.2.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
FY.1.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FY.1.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FY.1.2.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XBLORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XBLENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBLENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBLNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
EK.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
EK.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EK.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EK.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.466.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.466.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.466.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.466.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.177ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.177ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.36ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.36ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.36NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.222ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.222ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.222ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.222NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.470ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.470ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.470ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.470NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.31 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.31 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.31 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.31 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.51 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.51 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.51 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.51 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.122.5 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.122.5 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.122.5 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.122.5 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.40.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.40.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.40.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.40.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used